Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PDS Adds to API Auditing Team | Contract Pharma
Breaking News

PDS Adds to API Auditing Team

PDS is expanding its team of associates to meet growing demand for API auditing capability.

Pharmaceutical Development Services Ltd. (PDS) is expanding its team of associates to meet industry’s growing demand for API auditing capability. New PDS associates Paul Butler and Martin Slade have extensive CVs with particular expertise in API auditing in Europe, India and China, making them a valuable resource to companies seeking low cost, high quality API suppliers, according to a PDS statement.

PDS managing director Michael Gamlen said, “Having Martin and Paul available to add to the PDS body of expertise represents a considerable opportunity and I had no hesitation in bringing them onto the team. We are finding that API is a very hot topic at the moment. Some pharmaceutical sourcing, particularly from Asia, is proving of variable quality, leading to increased regulatory scrutiny. API Supplier Auditing is a key element of the international effort to maintain pharmaceutical supply chain integrity and avoid problems with counterfeit products and adulterated APIs. These appointments will consolidate PDS’ capability to offer comprehensive services to its growing number of US-based clients looking to benefit from services and product opportunities on a world wide basis.”

The company plans several more hires in this area in the immediate future.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters